Back

Nitisinone attenuates progression of aortic stenosis in patients with alkaptonuria: an analysis of the SONIA 2 study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: New molecular insights into valvular heart disease Aortic Valve Stenosis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Callum Bruce

The Royal Liverpool University Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Aortic valve stenosis augments long noncoding RNA H19 to govern angiogenic responses and phenotypes of valvular endothelial cell through endothelial to mesenchymal transition
Doctor M. Hosen (Bonn, DE)
Abstract Slides Video
Presentation thumbnail
Aortic valve disease augments vesicular microRNA-145-5p to regulate the calcification of valvular interstitial cells via cellular crosstalk
Doctor M. Hosen (Bonn, DE)
Abstract Slides
Presentation thumbnail
Effects of empagliflozin on myocardial transcriptome in rats with aortic stenosis-induced heart failure
Professor M. Okoshi (Botucatu, BR)
Abstract Slides Video
Presentation thumbnail
Impact of plasma from patients with severe aortic stenosis on valvular endothelial cells
Doctor A. Trimaille (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Paired single-cell RNA sequencing and T cell receptor sequencing reveals both pro- and anti-inflammatory roles of T cells in patients with calcific aortic valve disease
Miss X. Zhang (Wuhan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
New molecular insights into valvular heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Beyond the role of the mineralocorticoid receptor in aortic stenosis pathogenesis: a novel interplay between MR, NGAL signaling, and the innate immunity-TLR4 pathway
thumbnail
Congress Presentation
Association of circulating procollagen 1 N-terminal pro-peptide (P1NP) with clinical outcomes in asymptomatic patients with non-severe aortic valve stenosis: a post-hoc study of the SEAS trial
thumbnail
Congress Presentation
Current trends in aortic stenosis presentation, progression and treatment a retrospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources